chevrons

Back to Previous Page

Company Quarterly Earnings Update – DPM VN – 2018 Q3

Summary of the 9M 2018 results of Phu My Fertilizer (DPM VN) 

 

9M/2018 results: highlights
  • Net revenue rose by 7.9% thanks to higher urea sales. However, the gross margin declined due to higher input gas prices. The new NPK factory went into commercial operation in August and received good feedback from customers. However, production and sales were still low.
  • Selling and administration (SG&A) expenses, as a percentage of sales, declined significantly to 11.6% from 16.2% as a result of the Board of Director´s (BOD) efforts to eliminate redundant expenses. Net profit fell by 6.9% yoy to VND 551bn.
  • The new NPK factory was completed with a capex amount of VND 4,077bn. Despite these investments, DPM retained a strong balance sheet: cash and cash equivalents of VND 2,909bn, accounting for 25.0% of total assets.
Outlook
  • Urea selling prices in Vietnam should be supported by increasing production costs of other regional urea producers and by the expected end of global oversupply by 2020.
  • The NPK factory’s utilization rate is projected to improve to 90% and to 100% in 2019 and in 2020 respectively. We expect the EBITDA margin to be around 32% once the factory operates at full capacity.
  • DPM´s 2018 net profit should rise by 2.0% yoy, while we project a faster increase of 21.4% for 2019 thanks to higher urea selling prices and better margins from in-house NPK products.
Recommendation

Company ratings and target prices are accessible for clients only.

If you are interested in getting full access to our paid Primary Research Materials feel free to get in touch with us at your convenience.

Our team is actively covering 50 companies in the listed Vietnamese equity space for our clients.

 

Featured image credit: pvc.vn

Related News & Insights
Find out more navigation_button
news

Summary of 9M 2025 results and outlook of Nam Long Investment (NLG VN) The real estate market saw a rebound in new supply, supported by government initiatives that accelerated project development and sales launches. However, this recovery remains insufficient to narrow the supply-demand gap, as new launches are still concentrated in high-end and luxury segments. […]

Read Newsarrow
news

Summary of 9M 2025 results and outlook of Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD VN) Net revenue rose 8.5% y/y to VND1,355bn, driven by self-produced product sales, which accounted for 98.1% of total revenue. In Hospital channel: Revenue increased by 11.7% y/y to VND891bn, led by strong sales of key products including oncology […]

Read Newsarrow
news

Summary of 9M 2025 results and outlook of Hau Giang Pharmaceutical JSC (DHG VN) Net revenue grew 7.0% to VND3,524bn. In pharmacy channel (84.9% of total sales), early in the year, new tax and invoicing regulations posed challenges for traditional pharmacies, DHG’s main clients. It swiftly implemented support programs—including e-invoicing software assistance, promotional initiatives, and […]

Read Newsarrow
Find out more navigation_button